Home
Zambon S.p.A.

Zambon S.p.A. Market Share Analysis for August 2026

the zambon group is characterized by strong focus on quality in the production of medicines and research and development in specific therapeutic areas of excellence.

Health > Biotechnology and Pharmaceuticals

Domainzambon.com

Year Founded1906

Employees1001 - 5000

Annual Revenue$500M - $1B

Zambon S.p.A.

Zambon S.p.A. (including company regionals)

zambon.com

See more website traffic and engagement information

Zambon S.p.A. Revenue up to August 2026 is 500M - 1B

revenue generated by Zambon S.p.A. top domains

Zambon S.p.A. top domains revenue over 3 years

Revenue for Zambon S.p.A. top domains

zambon.com500M - 1B

See more with Sales Intelligence

Total visits to Zambon S.p.A.'s top domains

Understand Zambon S.p.A. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

zambon.com24.9K

See more with Sales Intelligence

Avg. visit duration in Zambon S.p.A.'s top domains

Analyze Zambon S.p.A. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

zambon.com00:00:24

See more with Sales Intelligence

Avg. pageviews on Zambon S.p.A.'s top domains

See how Zambon S.p.A. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

zambon.com1.59

See more with Sales Intelligence

Zambon S.p.A. top competitors by domain

Top similar sites in August 2026, ranked by their affinity

faesfarma.comCompany NameFAES FarmaEmployees1001 - 5000HQSpain, LeioaAnnual revenue$200M - $500MTotal visits46.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Zambon S.p.A.

These are the website technologies, by industry, used by Zambon S.p.A. top domains

Advertising (3)

DoubleClick

Email Services (3)

Microsoft Exchange Online

Social (3)

Instagram

Content Management System (2)

Drupal

More Technologies

7

See all

News & Signals from Zambon S.p.A.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsZambon S.p.A. launched Fluimucil intravenous formulation on Jun 1st '25.* In June 2025, a multinational chemical-pharmaceutical company, Zambon has announced the approval from Chinese regulatory authorities and the launch of the IV formulation of Fluimucil that helps effective patient care with respiratory illness.

NewsZambon S.p.A. launches Emylif.The pharmaceutical company Zambon has launched Emylif(R), an innovative buccal dispersible film formulation of Riluzole for the treatment of amyotrophic lateral sclerosis (ALS) in adults.

NewsKinaxis Inc. signed new client Zambon S.p.A. on Sep 23rd '24.OTTAWA, Ontario-(BUSINESS WIRE)-Kinaxis(R) Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced Zambon, a multinational pharmaceutical company committed to innovating cure and care to make patients' lives better, has selected Kinaxis to help orchestrate full visibility and transparency across its vast global supply chain.